Michael Khalil

9.8k total citations · 3 hit papers
104 papers, 4.5k citations indexed

About

Michael Khalil is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Michael Khalil has authored 104 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pathology and Forensic Medicine, 34 papers in Neurology and 26 papers in Molecular Biology. Recurrent topics in Michael Khalil's work include Multiple Sclerosis Research Studies (65 papers), Advanced Neuroimaging Techniques and Applications (13 papers) and RNA regulation and disease (12 papers). Michael Khalil is often cited by papers focused on Multiple Sclerosis Research Studies (65 papers), Advanced Neuroimaging Techniques and Applications (13 papers) and RNA regulation and disease (12 papers). Michael Khalil collaborates with scholars based in Austria, Netherlands and Switzerland. Michael Khalil's co-authors include Franz Fazekas, Charlotte E. Teunissen, Christian Enzinger, Stefan Ropele, Jens Kühle, Christian Barro, Christian Langkammer, Thomas Gattringer, Siegrid Fuchs and Henrik Zetterberg and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael Khalil

99 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurofilaments as biomarkers in neurological disorders

2018 1.3k citations Michael Khalil, Charlotte E. Teunissen et al. Nature Reviews Neurology profile →
Serum neurofilament light levels in normal aging and their association with morphologic brain changes

2020 380 citations Michael Khalil, Lukas Pirpamer et al. profile →
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management

2024 65 citations Michael Khalil, Jens Kühle et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Khalil	1.9k	1.5k	1.0k	709	528	104	4.5k
Gabriele C. DeLuca	3.0k 1.6×	1.2k 0.8×	1.0k 1.0×	790 1.1×	947 1.8×	126	5.8k
Bruno Stankoff	2.6k 1.3×	1.2k 0.8×	1.4k 1.3×	732 1.0×	1.1k 2.0×	129	5.8k
Jackie Palace	1.7k 0.9×	2.3k 1.5×	992 1.0×	566 0.8×	415 0.8×	64	5.1k
Mohsen Khademi	2.6k 1.4×	1.1k 0.7×	1.7k 1.7×	390 0.6×	901 1.7×	130	6.7k
Jens Wuerfel	2.9k 1.5×	1.7k 1.1×	779 0.8×	1.7k 2.4×	649 1.2×	143	6.3k
Yvonne Naegelin	2.1k 1.1×	967 0.6×	589 0.6×	477 0.7×	423 0.8×	83	3.5k
Federico Roncaroli	1.9k 1.0×	1.7k 1.1×	1.8k 1.8×	483 0.7×	1.3k 2.4×	210	7.2k
Thomas M. Bosley	1.2k 0.6×	1.6k 1.0×	1.3k 1.3×	520 0.7×	415 0.8×	172	5.6k
Helmut Butzkueven	4.3k 2.2×	1.6k 1.0×	1.1k 1.0×	533 0.8×	586 1.1×	295	7.2k
Henning Laursen	1.6k 0.8×	1.2k 0.8×	1.5k 1.4×	508 0.7×	1.0k 2.0×	118	5.5k

Countries citing papers authored by Michael Khalil

Since Specialization

Citations

This map shows the geographic impact of Michael Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Khalil more than expected).

Fields of papers citing papers by Michael Khalil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Khalil. The network helps show where Michael Khalil may publish in the future.

Co-authorship network of co-authors of Michael Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Khalil. A scholar is included among the top collaborators of Michael Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Khalil. Michael Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Opriessnig, Peter, Lukas Pirpamer, Edith Hofer, et al.. (2025). Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis. Neurology. 105(12). e214433–e214433.

Moser, Tobias, Michael Khalil, Jens Kühle, et al.. (2025). Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood Biomarkers. International Journal of Molecular Sciences. 26(6). 2629–2629.

Khalil, Michael, Petra Katschnig‐Winter, Edith Hofer, et al.. (2025). Serum glial fibrillary acidic protein is elevated in early-stage late-onset essential tremor and associated with tremor progression. Journal of Neural Transmission. 132(8). 1187–1195.

Ropele, Stefan, Gernot Reishofer, Sara Smock Jordan, et al.. (2025). Effects of rhythmic-cued gait training on gait-like task related brain activation in people with multiple sclerosis. Journal of the Neurological Sciences. 471. 123426–123426. 1 indexed citations

Madreiter‐Sokolowski, Corina T., Ursula Hiden, Jelena Krstić, et al.. (2024). Targeting organ-specific mitochondrial dysfunction to improve biological aging. Pharmacology & Therapeutics. 262. 108710–108710. 19 indexed citations

Wurth, Sebastian, et al.. (2024). Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis. NeuroImage Clinical. 42. 103606–103606. 1 indexed citations

Jauk, Emanuel, Stefan Ropele, Sebastian Wurth, et al.. (2024). Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting. Journal of Neurology. 271(6). 3268–3278. 4 indexed citations

Pinter, Daniela, et al.. (2024). Evaluation of the T25FW in minimally disabled people with multiple sclerosis. Journal of the Neurological Sciences. 462. 123073–123073. 2 indexed citations

Üçal, Muammer, Willibald Wonisch, Michaela Lang, et al.. (2023). Vitamin D—An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis. Nutrients. 15(15). 3309–3309. 8 indexed citations

10.

Penner, Iris‐Katharina, Lukas Pirpamer, Stefan Ropele, et al.. (2023). Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosis. Journal of the Neurological Sciences. 454. 120833–120833. 4 indexed citations

11.

Buchmann, Arabella, Lukas Pirpamer, Daniela Pinter, et al.. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. European Journal of Neurology. 30(5). 1389–1399. 8 indexed citations

12.

Khalil, Michael, Arabella Buchmann, Petra Katschnig‐Winter, et al.. (2023). Elevated serum neurofilament light chain protein in patients with essential tremor. European Journal of Neurology. 31(2). e16143–e16143. 6 indexed citations

13.

Schulz, Eduard, Angelika Lackner, Barbara Kleinhappl, et al.. (2023). Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy. Microbes and Infection. 25(4). 105103–105103. 2 indexed citations

14.

Fissolo, Nicolás, Clara Matute‐Blanch, Carme Costa, et al.. (2021). CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS. Neurology Neuroimmunology & Neuroinflammation. 8(2). 22 indexed citations

15.

Voortman, Margarete M., Lukas Pirpamer, Daniela Pinter, et al.. (2021). Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis. Biomolecules. 11(9). 1264–1264. 6 indexed citations

16.

Koini, Marisa, Lukas Pirpamer, Edith Hofer, et al.. (2021). Factors influencing serum neurofilament light chain levels in normal aging. Aging. 13(24). 25729–25738. 70 indexed citations

17.

Fissolo, Nicolás, Laura Cervera‐Carles, Alberto Lleó, et al.. (2018). Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis. Multiple Sclerosis Journal. 25(11). 1535–1538. 9 indexed citations

18.

Khalil, Michael, Charlotte E. Teunissen, Markus Otto, et al.. (2018). Neurofilaments as biomarkers in neurological disorders. Nature Reviews Neurology. 14(10). 577–589. 1305 indexed citations breakdown →

19.

Jehna, Margit, Lukas Pirpamer, Michael Khalil, et al.. (2015). Periventricular lesions correlate with cortical thinning in multiple sclerosis. Annals of Neurology. 78(4). 530–539. 31 indexed citations

20.

Jehna, Margit, Christian Langkammer, Michael Khalil, et al.. (2013). An Exploratory Study on the Spatial Relationship Between Regional Cortical Volume Changes and White Matter Integrity in Multiple Sclerosis. Brain Connectivity. 3(3). 255–264. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact